A clinical study to evaluate the efficacy of combined effect of Ayurvedic drugs and Basti in the management of constipation-predominant Irritable Bowel Syndrome vis-à-vis Pakvashayagatavata

Pragya Singhal


Constipation predominant Irritable bowel syndrome (IBS-C) vis-à-vis Pakwashayagatavata is a gut motility disorder associated with abdominal pain, constipation and bloated ness. A total of 25 patients suggestive of feature of Pakwashayagatavata or constipation predominant irritable bowel syndrome were enrolled and were randomly divided into two groups.  In Group A, 15 patients were enrolled and were given Panchasakarchoorna and Mahashankhavati. In Group B, 10 patients were enrolled and were given combination of Ayurvedic drugs (Panchasakarchoorna,Mahashankhavati) along with Bastifor a period of 16 days.Total duration of study was of 1 month. Both the groups had shown significant improvement in chronic constipation, bloating etc.(p<0.01),butgroup Bshowed better improvement in comparison to group A. Thus,Basti therapy is effective in the management of Pakwashayagatavata or constipation predominant IBS.


Pakwashayagatavata, irritable bowel syndrome, Basti


Wilson S, Roberts L, Roalfe A, Bridge P, Singh S (July 2004). "Prevalence of irritable bowel syndrome: a community survey". Br J Gen Pract 54 (504): 495–502. PMC 1324800. PMID. 15239910.

Schmulson MW, Chang L (1999). "Diagnostic approach to the patient with irritable bowel syndrome". Am. J. Med. 107(5A): 20S–26S.

Charaka,CharakaSamhita. CharakaChandrika Hindi commentary by BrahmanandTripathi.ChikitsaSthana 28verse 28 ChaukhambhaSubhartiPrakashana .Varanasi. page940 .

Byadgi PS et al ; Clinical evaluation of the modified shirodhara procedure &KukshiBasti in the management of Pakwashayagatavata (IBS) ; IJARP 2011 ,2(5) 1416-1422.

Charaka,CharakaSamhita. CharakaChandrika Hindi commentary by BrahmanandTripathi.ChikitsaSthana 28 verse 90.Chaukhambha SubhartiPrakashana .Varanasi. page 946 .

Charaka,CharakaSamhita, CharakaChandrika Hindi commentary by BrahmanandTripathi. ChikisaSthana 26 verse 11 .ChaukhambhaSubhartiPrakashana . Varanasi. Page 864.

Sushruta, SushrutaSamhita.AyurvedaTattvaSandipika by AmbikaduttShastri.ChikitsaSthana 4 verse 5. 11th edition .Chaukhambha Sanskrit Sansthan. Varanasi. 1997. Page 25.

Charaka,Dridhabala,CharakaSamhita, Siddhi Sthana, 1/32, edited by VaidyaJadavjiTrikamjiAcharya, 2ndedition, Chaukhamba Sanskrit Sansthan, Varanasi, 2008;108.

Charaka,CharakaSamhita, CharakaChandrika Hindi commentary byBrahmanandTripathi. Siddhi Sthana 10 verse 25-26 .ChaukhambhaSubhartiPrakashana . Varanasi. page 1303.

Ayurveda Sara Sangraha – Page 589.

Sri Govind das Bhaisajyaratnavali. Vidyotanihindi commentary by AmbikaduttShastri. AgnimandyaRogaAdhikara 186 – 187.ChaukhambhaChikitsaSansthan. Varanasi.

Esmaillzadeh A, Keshteli AH, Hajishafiee M, Feizi A, Feinle-Bisset C, Adibi P (2013). "Consumption of spicy foods and the prevalence of irritable bowel syndrome". World Journal of Gastroenterology 19 Improper diets causative factor

"IBS and Depression Connection and Treatments". Webmd.com. Retrieved 2012-10-21.

Charaka,CharakaSamhita.CharakaChandrikahindi commentary by BrahmanandTripathi.ChikitsaSthana 26, Verse 27.ChaukhambhaSubhartiPrakashan, Varanasi.

Sahasrayoga,Dr Ram Niwas Sharma and DrSurender Sharma. KashayaPrakarana: 428, Varanasi, ChaukhambaSanskritSansthan; 2012.

Charaka,CharakaSamhita.CharakaChandrikahindi commentary by BrahmanandTripathi .Siddhi Sthana 4, verse 13-16.ChaukhambaSubhartiPrakashana, Varanasi. Page 1214.

Bhavmishra, Edited by Chunekar KC, Pandey GS. BhavPrakashNighantu. Haritkayadiverga.Varanasi, ChaukhambaBharti Academy; 2006.

Bhavmishra, Edited by Chunekar KC, Pandey GS. BhavPrakashNighantu. Guduchiyadiverga.Varanasi, ChaukhambaBharti Academy; 2006.

NareshBansal, MunishSachdeva, Pankaj Jain, PiyushRanjan, Anil Arora Constipation Predominant Irritable Bowel Syndrome JIMSA January-March 2012 Vol. 25 No. 1 39.

Full Text: PDF


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.